Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy (original) (raw)

Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)

Raneem Hammouz

PLoS ONE, 2014

View PDFchevron_right

Expression of cell adhesion molecules in laryngeal carcinoma – preliminary analysis

Iwona Lewy-Trenda

Współczesna Onkologia, 2014

View PDFchevron_right

EpCAM expression in squamous cell carcinoma of the oral cavity: Frequency and relationship to clinicopathologic features

Stefan Hosch, Robert Gassner

Oral Oncology, 2008

View PDFchevron_right

Cancer-Related Signals of Epithelial Cell Adhesion Molecule (EpCAM): Review

Sheren Ahmed

2020

View PDFchevron_right

Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer

George Wilson

European Journal of Cancer, 2004

View PDFchevron_right

Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression

Gioacchino Giugliano

Medical oncology (Northwood, London, England), 2017

View PDFchevron_right

Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression

Haralabos Koussis

European Archives of Oto-Rhino-Laryngology, 2011

View PDFchevron_right

Association of epidermal growth factor receptor protein expression with histopathological and clinical parameters in carcinoma of the larynx

Amein Al-Ali

Translational Cancer Research

View PDFchevron_right

Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis

Barbara Burtness

Clinical Cancer Research, 2005

View PDFchevron_right

Prognostic factors in head and neck cancer

Mwm Van Den Brekel

European Journal of Cancer, 2002

View PDFchevron_right

Adhesion Molecules as Prognostic Factors in Nasopharyngeal Carcinoma

Mark Delacure

The Laryngoscope, 2001

View PDFchevron_right

Effects of EGFR, CK19, CK20 and Survinin Gene Expression on Radiotherapy Results in Patients with Locally Advanced Head and Neck Cancer

Berrin Tunca

Asian Pacific journal of cancer prevention : APJCP, 2015

View PDFchevron_right

Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers

Carol Box

Frontiers in Bioscience, 2013

View PDFchevron_right

Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma

Giovanni Storto, Alba Fiorentino

Radiation Oncology, 2012

View PDFchevron_right

Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell Carcinoma

Andy Trotti

International Journal of Radiation Oncology*Biology*Physics, 2011

View PDFchevron_right

Local Recurrence in Head and Neck Cancer Relationship to Radiation Resistance and Signal Transduction

Gillies McKenna

Clinical Cancer Research an Official Journal of the American Association For Cancer Research, 2002

View PDFchevron_right

Response to Therapy and Outcomes In Oropharyngeal Cancer Are Associated With Biomarkers Including Human Papillomavirus, Epidermal Growth Factor Receptor, …

Avraham Eisbruch

International Journal of …, 2007

View PDFchevron_right

WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer

Björn Palmgren

Oncology Reports

View PDFchevron_right

Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse

Jacopo Galli

International journal of cancer. Journal international du cancer, 1999

View PDFchevron_right

Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histological Grading

Isabel Vilaseca

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018

View PDFchevron_right

Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas

Barbara Wollenberg, Olivier Gires

Cancer Letters, 2003

View PDFchevron_right

Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients

Ajay Matta, Jatinder Kaur

International Journal of Cancer, 2009

View PDFchevron_right

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: Results from a randomised, phase II trial

Upendra Parvathaneni

2013

View PDFchevron_right

Radioresistant head and neck squamous cell carcinoma cells: Intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets

Peter Lukas

Radiotherapy and Oncology, 2011

View PDFchevron_right

Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy

Nina Gale

Radiology and Oncology, 2015

View PDFchevron_right

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck

Jesper Eriksen

International Journal of Radiation Oncology*Biology*Physics, 2004

View PDFchevron_right